PTN logo

PTN
Palatin Technologies Inc.

24,764
Mkt Cap
$5.74M
Volume
0.00
52W High
$72.50
52W Low
$1.75
PE Ratio
-0.16
PTN Fundamentals
50D MA
$8.38
Beta
0.37
Avg. Volume
3,157.43
EPS (Annual)
-$32.15
P/B
-1.15
Rev/Employee
$0.00
Loading...
Loading...
Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
29

Frequently Asked Questions

What is Market Cap of Palatin Technologies Inc.?
What is the 52-week high for Palatin Technologies Inc.?
What is the 52-week low for Palatin Technologies Inc.?
What is the PE ratio of Palatin Technologies Inc.?
What is the Price-to-Book ratio of Palatin Technologies Inc.?
What is the 50-day moving average of Palatin Technologies Inc.?
How many employess does Palatin Technologies Inc. has?

Latest PTN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.